Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • 7. - Where Gender, Sex and Mental Health Collide

  • Linda Gask, University of Manchester
  • Book:
    Out of Her Mind
    Published online:
    10 October 2024
    Print publication:
    10 October 2024, pp 131-148

  • Summary

    Those identifying as LGBTQ+ experience an excess of mental health problems and suicide in our society, and their mental health needs are poorly catered for. In the recent past, aversion therapy was given to lesbian and transwomen and conversion therapy remains legal. The ‘gender wars’ have also opened up spaces within society and feminism that can be difficult to negotiate. For transwomen, timely access to adequate care remains a major problem causing considerable emotional distress while public anti-trans sentiment has increased. Repeated denial of the lived experience of trans people is causing psychological harm. The rise in gender dysphoria in assigned female at birth (AFAB; or natal female) girls and their treatment has caused major controvery. We must to acknowledge both the distress of trans people, who feel frustrated and angry at having to jump through the hoops of psychiatric assessment and being blamed for male violence from which they are also at risk, and the distress and fear of women who have been conditioned lifelong to fear, and/or have experienced violence, at losing their safe spaces. Seeking ways to ensure that everyone feels welcomed not only in services but also in society.

  • Stroke in Male-to-Female Transgenders: A Systematic Review and Meta-Analysis

  • Katrina Hannah D. Ignacio, Jose Danilo B. Diestro, Adrian I. Espiritu, Maria Carissa Pineda-Franks
  • Journal:
    Canadian Journal of Neurological Sciences / Volume 49 / Issue 1 / January 2022
    Published online by Cambridge University Press:
    26 March 2021, pp. 76-83
    • Article
      • You have access
    • PDF
    • HTML
    • Export citation
  • Background:

    The effect of hormonal therapy has been extensively studied in women. However, similar data on male-to-female (MTF) transgenders, another important population that receives hormonal therapy is lacking. Existing studies in MTF transgenders are skewed toward mental health and health-harming behaviors while few have focused on chronic health conditions. Our study aims to review the existing data on stroke in MTF transgenders and perform a quantitative analysis on the frequency of this condition in this special population.

    Methods:

    PubMed, Cochrane, Scopus, Embase, ClinicalTrials.gov, and Web of Science were systematically searched for studies that reported data on the occurrence of cerebrovascular diseases in MTF transgenders. We reported the hormonal regimens, clinical characteristics, and outcomes of stroke in MTF transgenders. A meta-analysis of proportions was performed by the random-effects model to compute for the frequency of cerebrovascular events in MTF transgenders.

    Results:

    Fourteen studies were included in the qualitative analysis while five studies were included in the quantitative analysis. A total of 109 MTF transgenders (Mean 14; range 1–53) suffered a cerebrovascular event. Random-effect modeling analysis showed an overall estimated frequency of 2% for cerebrovascular events in transgenders with a moderate degree of heterogeneity (I2 = 62%).

    Conclusion:

    Hormonal therapy in MTF transgenders may confer cardiovascular risks in this population. However, more population-based studies that include clinical characteristics and outcomes of chronic health diseases in MTF transgenders are warranted. Such studies may be crucial in directing future guidelines on the health care and management of MTF transgenders.